Fibrotic injury after experimental deep vein thrombosis is determined by the mechanism of thrombogenesis

Thrombosis and Haemostasis

Volumn 98, Issue 5, 2007, Pages 1045-1055

  Henke, Peter K ^a,b   Varma, Manu R ^a   Moaveni, Daria K ^a   Dewyer, Nicholas A ^a   Moore, Andrea J ^a   Lynch, Erin M ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b NONE   (United States)

Author keywords

Collagen; Inflammation; Thrombosis; Vascular biology; Veins

Indexed keywords

CANCER GROWTH FACTOR; GELATINASE A; GELATINASE B; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ARTICLE; BLOOD VESSEL INJURY; CELL PROLIFERATION; COLLAGEN DEGRADATION; CORRELATION ANALYSIS; DEEP VEIN THROMBOSIS; GENE EXPRESSION; HYPOTHESIS; INFERIOR CAVA VEIN; INFLAMMATION; MALE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RAT; RESPONSE TIME; THROMBOGENESIS; THROMBUS; VEIN LIGATION; VEIN WALL;

ANIMALS; CELL PROLIFERATION; CYTOKINES; DISEASE MODELS, ANIMAL; ENDOTHELIUM, VASCULAR; EXTRACELLULAR MATRIX; FIBROSIS; INFLAMMATION; MALE; MATRIX METALLOPROTEINASES; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS; URINARY PLASMINOGEN ACTIVATOR; VENA CAVA, INFERIOR; VENOUS THROMBOSIS;

EID: 36049034381     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH07-03-0190     Document Type: Article

References (33)

1. Heit JA, Silverstein MD, Mohr DN, et al. The epidemiology of venous thromboembolism in the community. Thromb Haemost 2001; 86: 452-463.
2. Prandoni P, Lensing AW, Cogo A, et al. The longterm clinical course of acute deep venous thrombosis. Ann Intern Med 1996; 125: 1-7.
3. Delis KT, Bountouroglou D, Mansfield AO.Venous claudication in iliofemoral thrombosis: Long-term effects on venous hemodynamics, clinical status, and quality of life. Ann Surg 2004; 239: 118-126.
4. Henke PK, Pearce CG, Moaveni DM, et al. Targeted deletion of CCR2 impairs deep vein thombosis resolution in a mouse model. J Immunol 2006; 177: 3388-3397.
5. Henke PK, Varga A, De S, et al. Deep vein thrombosis resolution is modulated by monocyte CXCR2-mediated activity in a mouse model. Arterioscler Thromb Vasc Biol 2004; 24: 1130-1137.
6. Wakefield TW, Strieter RM, Wilke CA, et al. Venous thrombosis-associated inflammation and attenuation with neutralizing antibodies to cytokines and adhesion molecules. Arterioscler Thromb Vasc Biol 1995; 15: 258-268.
7. Myers DD, Jr., Henke PK, Bedard PW, et al. Treatment with an oral small molecule inhibitor of P selectin (PSI-697) decreases vein wall injury in a rat stenosis model of venous thrombosis. J Vasc Surg 2006; 44: 625-632.
8. Deatrick KB, Eliason JL, Lynch EM, et al. Vein wall remodeling after deep vein thrombosis involves matrix metalloproteinases and late fibrosis in a mouse model. J Vasc Surg 2005; 42: 140-148.
9. Henke PK, Varma MR, Deatrick KB, et al. Neutrophils modulate post-thrombotic vein wall remodeling but not thrombus neovascularization. Thromb Haemost 2006; 95: 272-281.
10. Meissner MH, Manzo RA, Bergelin RO, et al. Deep venous insufficiency: the relationship between lysis and subsequent reflux. J Vasc Surg 1993; 18: 596-605; discussion 606-608.
11. Mewissen MW. Catheter-directed thrombolysis for lower extremity deep vein thrombosis. Tech Vasc Interv Radiol 2001; 4: 111-114.
12. See-Tho K, Harris EJ, Jr. Thrombosis with outflow obstruction delays thrombolysis and results in chronic wall thickening of rat veins. J Vasc Surg 1998; 28 115-122; discussion 123.
13. Visse R, Nagase H. Matrix metalloproteinases an tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res 2003; 92: 827-839.
14. Coats WD, Jr., Whittaker P, Cheung DT, et al. Collagen content is significantly lower in restenotic versus nomestenotic vessels after balloon angioplasty in the atherosclerotic rabbit model. Circulation 1997; 95 1293-1300.
15. Zhu YK, Liu X, Wang H, et al. Interactions between monocytes and smooth-muscle cells can lead to extra-cellular matrix degradation. J Allergy Clin Immunol 2001; 108: 989-996.
16. Gillitzer I, Goebeler M. Chemokines in cutaneous wound healing. J Leukoc Biol 2001; 69: 513-521.
17. Brasselet C, Durand E, Addad F, et al. Collagen and elastin cross-linking: a mechanism of constrictive remodeling after arterial injury. Am J Physiol Heart Cir Physiol 2005; 289: H2228-2233.
18. Shanley CJ, Gharace-Kermani M, Sarkar R, et al. Transforming growth factor-beta I increases lysyl oxidase enzyme activity and mRNA in rat aortic smooth muscle cells. J Vasc Surg 1997; 25: 446-452.
19. Rectenwald JE, Deatrick KB, Sukheepod P, et al. Experimental pulmonary embolism: effects of the thrombus and attenuation of pulmonary artery injur by low-molecular-weight heparin. J Vasc Surg 2006; 43: 800-808.
20. Zhu Y, Farrehi PM, Fay WP. Plasminogen activator inhibitor type I enhances neointima formation after oxidative vascular injury in atherosclerosis-prone mice. Circulation 2001; 103: 3105-3110.
21. Borges LF, Gutierrez PS, Marana HR, et al. Picrosirius-polarization staining method as an efficient histo-pathological tool for collagenolysis detection in vesical prolapse lesions. Micron 2007; 38: 580-583.
22. Cuttle L, Nataatmadja M, Fraser JF, et al. Collagen in the scarless fetal skin wound: detection with picrosirius-polarization. Wound Repair Regen 2005; 13: 198-204.
23. Ginzinger DG. Gene quantification using real-time quantitative PCR: an emerging technology hits the mainstream. Exp Hematol 2002; 30: 503-512.
24. Newby AC. Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture. Physiol Rev 2005; 85: 1-31.
25. Garcia-Touchard A, Henry TD, Sangiorgi G, et al. Extracellular proteases in atherosclerosis and restenosis. Arterioscler Thromb Vasc Biol 2005; 25: 1119-1127.
26. Lijnen HR, Van Hoef B, Lupu F, et al. Function of the plasminogen/ plasmin and matrix metalloproteinase systems after vascular injury in mice with targeted in-activation of fibrinolytic system genes. Arterioscler Thromb Vasc Biol 1998; 18: 1035-1045.
27. Davis GE, Senger DR. Endothelial extracellular matrix: biosynthesis, remodeling, and functions during vascular morphogenesis and neovessel stabilization. Circ Res 2005; 97: 1093-1107.
28. Taipale J, Keski-Oja J. Growth factors in the extra-cellular matrix. Faseb J 1997; 11: 51-59.
29. Singh I, Burnand KG, Collins M, et al. Failure of thrombus to resolve in urokinase-type plasminogen activator gene-knockout mice: rescue by normal bone marrow-derived cells. Circulation 2003; 107:869-875.
30. Strauss BH, Chisholm RJ, Keeley FW, et al. Extra-cellular matrix remodeling after balloon angioplasty injury in a rabbit model of restenosis. Circ Res 1994; 75: 65-658.
31. Kovacs EJ. Fibrogenic cytokines: the role of immune mediators in the development of scar tissue, Immunol Today 1991; 12: 17-23.
32. Chou DH-I, Lee W McCulloch CA. TNFα inactivation of collagen receptors. J Immunol 1996; 156: 4354-4362.
33. Houghton AM, Quintero PA, Perkins DL, et al. Elastin fragments drive disease progression in a murine model of emphysema. J Clin Invest 2006; 116: 753-759.